share_log

Lake Street Maintains Buy on Ensysce Biosciences, Adjusts Price Target to $8 - 1-for-20 Reverse Stock Split

Lake Street Maintains Buy on Ensysce Biosciences, Adjusts Price Target to $8 - 1-for-20 Reverse Stock Split

Lake Street維持對Ensysce Biosciences的買入,將目標價調整為20股換8股
Benzinga Real-time News ·  2022/11/17 10:08

Lake Street analyst Thomas Flaten maintains Ensysce Biosciences (NASDAQ:ENSC) with a Buy, adjusts price target to $8 - 1-for-20 reverse stock split.

Lake Street分析師託馬斯·弗拉頓維持恩賽斯生物科學公司(納斯達克股票代碼:ENSC)的買入,將目標價調整為20股8-1股的反向股票拆分。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論